Published in Vet Microbiol on February 26, 2009
Rapid evolution of virulence and drug resistance in the emerging zoonotic pathogen Streptococcus suis. PLoS One (2009) 2.38
Streptococcus suis, an important pig pathogen and emerging zoonotic agent-an update on the worldwide distribution based on serotyping and sequence typing. Emerg Microbes Infect (2014) 2.24
Lineage and virulence of Streptococcus suis serotype 2 isolates from North America. Emerg Infect Dis (2011) 1.50
The minor pilin subunit Sgp2 is necessary for assembly of the pilus encoded by the srtG cluster of Streptococcus suis. J Bacteriol (2010) 1.10
Genetic diversity of Streptococcus suis isolates as determined by comparative genome hybridization. BMC Microbiol (2011) 1.04
Identification of genes and genomic islands correlated with high pathogenicity in Streptococcus suis using whole genome tiling microarrays. PLoS One (2011) 0.93
Identification of a novel streptococcal adhesin P (SadP) protein recognizing galactosyl-α1-4-galactose-containing glycoconjugates: convergent evolution of bacterial pathogens to binding of the same host receptor. J Biol Chem (2011) 0.92
Mutations in the gene encoding the ancillary pilin subunit of the Streptococcus suis srtF cluster result in pili formed by the major subunit only. PLoS One (2010) 0.91
First human case report of sepsis due to infection with Streptococcus suis serotype 31 in Thailand. BMC Infect Dis (2015) 0.86
Streptococcus suis in invasive human infections in Poland: clonality and determinants of virulence and antimicrobial resistance. Eur J Clin Microbiol Infect Dis (2016) 0.86
Complex Population Structure and Virulence Differences among Serotype 2 Streptococcus suis Strains Belonging to Sequence Type 28. PLoS One (2015) 0.86
Functional identification of conserved residues involved in Lactobacillus rhamnosus strain GG sortase specificity and pilus biogenesis. J Biol Chem (2014) 0.84
Dynamics of fecal microbial communities in children with diarrhea of unknown etiology and genomic analysis of associated Streptococcus lutetiensis. BMC Microbiol (2013) 0.84
Comparative genomic hybridization identifies virulence differences in Streptococcus suis. PLoS One (2014) 0.81
Virulence Studies of Different Sequence Types and Geographical Origins of Streptococcus suis Serotype 2 in a Mouse Model of Infection. Pathogens (2016) 0.80
Population Structure and Antimicrobial Resistance Profiles of Streptococcus suis Serotype 2 Sequence Type 25 Strains. PLoS One (2016) 0.80
Pilus biogenesis of Gram-positive bacteria: Roles of sortases and implications for assembly. Protein Sci (2017) 0.76
A hypothetical model of host-pathogen interaction of Streptococcus suis in the gastro-intestinal tract. Gut Microbes (2016) 0.76
A locus encoding variable defence systems against invading DNA identified in Streptococcus suis. Genome Biol Evol (2017) 0.75
Bacterial Adhesion of Streptococcus suis to Host Cells and Its Inhibition by Carbohydrate Ligands. Biology (Basel) (2013) 0.75
The truncated major pilin subunit Sbp2 of the srtBCD pilus cluster still contributes to Streptococcus suis pathogenesis in the absence of pilus shaft. Curr Microbiol (2014) 0.75
Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice. Circulation (2005) 2.79
Clinical, experimental, and genomic differences between intermediately pathogenic, highly pathogenic, and epidemic Streptococcus suis. J Infect Dis (2009) 2.49
Rapid evolution of virulence and drug resistance in the emerging zoonotic pathogen Streptococcus suis. PLoS One (2009) 2.38
The relationship of tryptase- and chymase-positive mast cells to angiogenesis in stage I non-small cell lung cancer. Eur J Cardiothorac Surg (2005) 2.17
Caspase 1-independent activation of interleukin-1beta in neutrophil-predominant inflammation. Arthritis Rheum (2009) 2.16
Virulence factors involved in the pathogenesis of the infection caused by the swine pathogen and zoonotic agent Streptococcus suis. Future Microbiol (2012) 2.10
Streptococcus suis sequence type 7 outbreak, Sichuan, China. Emerg Infect Dis (2006) 2.07
Leflunomide protects from T-cell-mediated liver injury in mice through inhibition of nuclear factor kappaB. Hepatology (2004) 1.76
Biochemical analysis, cpn60 and 16S rDNA sequence data indicate that Streptococcus suis serotypes 32 and 34, isolated from pigs, are Streptococcus orisratti. Vet Microbiol (2005) 1.74
Characterization of Streptococcus suis isolates recovered between 2008 and 2011 from diseased pigs in Québec, Canada. Vet Microbiol (2012) 1.69
Streptococcus suis serotype 2, an important swine and human pathogen, induces strong systemic and cerebral inflammatory responses in a mouse model of infection. J Immunol (2007) 1.65
Expression of chymase-positive cells in gastric cancer and its correlation with the angiogenesis. J Surg Oncol (2006) 1.50
Chronic chymase inhibition preserves cardiac function after left ventricular repair in rats. Eur J Cardiothorac Surg (2007) 1.50
Lineage and virulence of Streptococcus suis serotype 2 isolates from North America. Emerg Infect Dis (2011) 1.50
Characterization of Streptococcus suis genes encoding proteins homologous to sortase of gram-positive bacteria. J Bacteriol (2002) 1.49
The effects of chymase on matrix metalloproteinase-2 activation in neointimal hyperplasia after balloon injury in dogs. Hypertens Res (2007) 1.45
Distinct signatures of diversifying selection revealed by genome analysis of respiratory tract and invasive bacterial populations. Proc Natl Acad Sci U S A (2011) 1.39
A review of enzymes and microbes for lignocellulosic biorefinery and the possibility of their application to consolidated bioprocessing technology. Bioresour Technol (2012) 1.39
Phagocytosis and killing of Streptococcus suis by porcine neutrophils. Microb Pathog (2006) 1.39
Significant contribution of the pgdA gene to the virulence of Streptococcus suis. Mol Microbiol (2008) 1.38
Population structure of invasive and colonizing strains of Streptococcus agalactiae from neonates of six U.S. Academic Centers from 1995 to 1999. J Clin Microbiol (2008) 1.38
Pro-inflammatory cytokine and chemokine release by human brain microvascular endothelial cells stimulated by Streptococcus suis serotype 2. FEMS Immunol Med Microbiol (2003) 1.36
Sepsis and spontaneous bacterial peritonitis in Thailand. Lancet (2011) 1.33
Diversity of Melissococcus plutonius from honeybee larvae in Japan and experimental reproduction of European foulbrood with cultured atypical isolates. PLoS One (2012) 1.32
Group A Streptococcus emm gene types in pharyngeal isolates, Ontario, Canada, 2002-2010. Emerg Infect Dis (2011) 1.32
Adhesive surface proteins of Erysipelothrix rhusiopathiae bind to polystyrene, fibronectin, and type I and IV collagens. J Bacteriol (2003) 1.31
Streptococcus suis infection: a series of 41 cases from Chiang Mai University Hospital. J Infect (2006) 1.29
Human disease isolates of serotype m4 and m22 group a streptococcus lack genes required for hyaluronic acid capsule biosynthesis. MBio (2012) 1.27
TLR2-dependent recognition of Streptococcus suis is modulated by the presence of capsular polysaccharide which modifies macrophage responsiveness. Int Immunol (2007) 1.25
Serotype III Streptococcus agalactiae from bovine milk and human neonatal infections. Emerg Infect Dis (2004) 1.25
Distribution of Streptococcus suis capsular types from 2001 to 2007. Can Vet J (2008) 1.24
Down-regulation of DUSP6 expression in lung cancer: its mechanism and potential role in carcinogenesis. Am J Pathol (2009) 1.24
Metabolic pathway engineering based on metabolomics confers acetic and formic acid tolerance to a recombinant xylose-fermenting strain of Saccharomyces cerevisiae. Microb Cell Fact (2011) 1.23
Genotypic profile of Streptococcus suis serotype 2 and clinical features of infection in humans, Thailand. Emerg Infect Dis (2011) 1.23
Serotype distribution and production of muramidase-released protein, extracellular factor and suilysin by field strains of Streptococcus suis isolated in the United States. Vet Microbiol (2009) 1.22
Invasion of porcine brain microvascular endothelial cells by Streptococcus suis serotype 2. Infect Immun (2004) 1.22
Isolation and characterization of alpha-enolase, a novel fibronectin-binding protein from Streptococcus suis. Microbiology (2008) 1.22
Genetic analysis of capsular polysaccharide synthesis gene clusters from all serotypes of Streptococcus suis: potential mechanisms for generation of capsular variation. Appl Environ Microbiol (2013) 1.22
Egr-1 mediates transcriptional repression of COL2A1 promoter activity by interleukin-1beta. J Biol Chem (2003) 1.22
Host-pathogen interactions of Actinobacillus pleuropneumoniae with porcine lung and tracheal epithelial cells. Infect Immun (2009) 1.22
Dilemma of virulence of Streptococcus suis: Canadian isolate 89-1591 characterized as a virulent strain using a standardized experimental model in pigs. Can J Vet Res (2005) 1.22
Complete genome sequence of Melissococcus plutonius ATCC 35311. J Bacteriol (2011) 1.21
Streptococcus suis in humans, Thailand. Emerg Infect Dis (2008) 1.21
Encapsulated Streptococcus suis inhibits activation of signaling pathways involved in phagocytosis. Infect Immun (2004) 1.20
Pathological roles of angiotensin II produced by mast cell chymase and the effects of chymase inhibition in animal models. Pharmacol Ther (2006) 1.19
Intravenously transplanted human neural stem cells migrate to the injured spinal cord in adult mice in an SDF-1- and HGF-dependent manner. Neurosci Lett (2007) 1.18
Structure determination of Streptococcus suis serotype 2 capsular polysaccharide. Biochem Cell Biol (2010) 1.15
Angiotensin II receptor type 1-mediated vascular oxidative stress and proinflammatory gene expression in aldosterone-induced hypertension: the possible role of local renin-angiotensin system. Endocrinology (2007) 1.15
Minimum core genome sequence typing of bacterial pathogens: a unified approach for clinical and public health microbiology. J Clin Microbiol (2013) 1.15
Prevalence of Actinobacillus pleuropneumoniae, Actinobacillus suis, Haemophilus parasuis, Pasteurella multocida, and Streptococcus suis in representative Ontario swine herds. Can J Vet Res (2008) 1.14
Development and implementation of a database system to manage a large-scale mouse ENU-mutagenesis program. Mamm Genome (2004) 1.14
Angiotensin receptor-1 blocker inhibits atherosclerotic changes and endothelial disruption of the aortic valve in hypercholesterolemic rabbits. J Am Coll Cardiol (2007) 1.14
Tissue angiotensin II generating system by angiotensin-converting enzyme and chymase. J Pharmacol Sci (2006) 1.13
Critical role for Streptococcus suis cell wall modifications and suilysin in resistance to complement-dependent killing by dendritic cells. J Infect Dis (2011) 1.12
Genetic diversity of Streptococcus suis strains isolated from pigs and humans as revealed by pulsed-field gel electrophoresis. J Clin Microbiol (2002) 1.12
Streptococcus suis interactions with the murine macrophage cell line J774: adhesion and cytotoxicity. Infect Immun (2002) 1.11
Spread of Streptococcus suis sequence type 7, China. Emerg Infect Dis (2008) 1.11
Meningitis caused by Streptococcus suis serotype 14, North America. Emerg Infect Dis (2009) 1.11
D-alanylation of lipoteichoic acid contributes to the virulence of Streptococcus suis. Infect Immun (2008) 1.11
Loss of capsule among Streptococcus suis isolates from porcine endocarditis and its biological significance. J Med Microbiol (2011) 1.11
The minor pilin subunit Sgp2 is necessary for assembly of the pilus encoded by the srtG cluster of Streptococcus suis. J Bacteriol (2010) 1.10
Rhodococcus equi can survive a phagolysosomal environment in macrophages by suppressing acidification of the phagolysosome. J Med Microbiol (2005) 1.10
Identification of a surface protein of Streptococcus suis and evaluation of its immunogenic and protective capacity in pigs. Infect Immun (2006) 1.10
Comparison of the susceptibilities of C57BL/6 and A/J mouse strains to Streptococcus suis serotype 2 infection. Infect Immun (2008) 1.08
A sandwich enzyme-linked immunosorbent assay for human plasma apolipoprotein A-V concentration. J Lipid Res (2005) 1.08
Antimicrobial resistance and prudent drug use for Streptococcus suis. Anim Health Res Rev (2013) 1.08
Development of multiplex PCR assays for the identification of the 33 serotypes of Streptococcus suis. PLoS One (2013) 1.08
Proinflammatory cytokine and chemokine modulation by Streptococcus suis in a whole-blood culture system. FEMS Immunol Med Microbiol (2006) 1.07
Distribution of capsular serotypes and virulence markers of Streptococcus suis isolated from pigs with polyserositis in Korea. Can J Vet Res (2010) 1.07
Molecular epidemiology of Rhodococcus equi of intermediate virulence isolated from patients with and without acquired immune deficiency syndrome in Chiang Mai, Thailand. J Infect Dis (2003) 1.07
Cloning and purification of the Streptococcus suis serotype 2 glyceraldehyde-3-phosphate dehydrogenase and its involvement as an adhesin. Vet Microbiol (2004) 1.07
Chymase inhibition reduces infarction and matrix metalloproteinase-9 activation and attenuates inflammation and fibrosis after acute myocardial ischemia/reperfusion. J Pharmacol Exp Ther (2011) 1.06
ESE-1 is a potent repressor of type II collagen gene (COL2A1) transcription in human chondrocytes. J Cell Physiol (2008) 1.06
Outcome of rotational acetabular osteotomy for early hip osteoarthritis secondary to dysplasia related to femoral head shape: 49 hips followed for 10-17 years. Acta Orthop (2008) 1.05
Cell surface characteristics of nontypeable isolates of Streptococcus suis. FEMS Microbiol Lett (2010) 1.05
Correlation between angiotensin-converting enzyme, vascular endothelial growth factor, and matrix metalloproteinase-9 in the vitreous of eyes with diabetic retinopathy. Am J Ophthalmol (2006) 1.05
Immunization with recombinant Sao protein confers protection against Streptococcus suis infection. Clin Vaccine Immunol (2007) 1.05
Interactions of Haemophilus parasuis and its LOS with porcine brain microvascular endothelial cells. Vet Res (2008) 1.04
Population structure and antimicrobial resistance of invasive serotype IV group B Streptococcus, Toronto, Ontario, Canada. Emerg Infect Dis (2015) 1.04
Early growth response-1 induces and enhances vascular endothelial growth factor-A expression in lung cancer cells. Am J Pathol (2010) 1.04
Genetic engineering to enhance the Ehrlich pathway and alter carbon flux for increased isobutanol production from glucose by Saccharomyces cerevisiae. J Biotechnol (2012) 1.04